Frontiers in bioscience (Landmark edition)AnimalsCyclophosphamideFemaleMicePrimary Ovarian Insufficiency
Irisolidone Ameliorates Cyclophosphamide-Induced POI via Inhibiting Inflammatory Response.
Mingjin Li, Zhenhong Wei, Xiaohong Chen, Huifang Wu, Xue Han, Yaping Pei, Jiyu Chen, Shouye Ma
Published: 202510.31083/FBL45744
Abstract
BACKGROUND: Premature ovarian insufficiency (POI) is a condition marked by diminished ovarian function and reduced fertility, caused by the chemotherapy drug cyclophosphamide (CTX) used to treat gynecologic cancers. The abnormal inflammation of ovari…
Preview only. Read the full abstract at the source